Summary & Overview
CPT 50953: Percutaneous Ureteroscopic Examination and Catheterization
CPT code 50953 represents a percutaneous endoscopic examination of the kidney, renal pelvis, and ureter performed through an existing skin-to-ureter tract, including ureteral catheterization and optional dilation. This procedure is clinically important for diagnostic evaluation and management of upper urinary tract conditions when access is already established, and it is commonly performed in ambulatory surgery centers and hospital operating rooms. Nationally, utilization of targeted endoscopic urologic procedures informs resource planning for surgical suites and specialty care access.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a concise overview of coding intent and clinical context, payer coverage considerations, common modifiers, and related administrative details where available. Readers will find benchmarks and policy-relevant summaries, clinical context that clarifies when the code applies, and coding guidance for proper claim representation. Data not available in the input is noted where applicable. The report is intended for health system administrators, reimbursement analysts, and specialty providers seeking a national perspective on billing and clinical use for CPT code 50953.
Billing Code Overview
CPT code 50953 describes an endoscopic examination of the kidney, renal pelvis, and ureter performed through an existing percutaneous or cutaneous tract between the skin and the ureter. The service includes catheterization of the ureter and may include ureteral dilation when performed.
-
Service type: Endoscopic urologic diagnostic/operative procedure (percutaneous ureteroscopic evaluation and catheterization)
-
Typical site of service: Ambulatory surgery center or hospital operating room (procedures performed through an established skin-to-ureter tract)
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting with flank pain, hematuria, recurrent urinary tract infections, or suspected ureteral obstruction. After initial evaluation with history, physical exam, urinalysis, and imaging (ultrasound or CT urogram) demonstrates suspected ureteral pathology such as obstruction from a ureteral stricture or stone, the urologist schedules a diagnostic ureteroscopy via an existing percutaneous nephrostomy tract. In the interventional suite or operating room the provider accesses the renal collecting system through the previously established percutaneous skin-to-ureter tract, passes the ureteroscope to examine the kidney, renal pelvis, and ureter, performs catheterization of the ureter, and may dilate a narrowed ureteral segment for visualization or drainage. The workflow typically includes pre-procedure consent, review of imaging and nephrostomy tract maturity, anesthesia evaluation (general or monitored anesthesia care), intra-procedural fluoroscopy as needed, documentation of findings (stones, strictures, tumors, inflammation), and post-procedure monitoring with plans for stent placement, further endourologic intervention, or removal of the nephrostomy tube as indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When reporting only the physician’s interpretation/professional portion if a separate technical component was billed by facility |